JP2021502573A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021502573A5 JP2021502573A5 JP2020544567A JP2020544567A JP2021502573A5 JP 2021502573 A5 JP2021502573 A5 JP 2021502573A5 JP 2020544567 A JP2020544567 A JP 2020544567A JP 2020544567 A JP2020544567 A JP 2020544567A JP 2021502573 A5 JP2021502573 A5 JP 2021502573A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- steps
- peripheral
- protein
- peripheral arterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762580916P | 2017-11-02 | 2017-11-02 | |
| US62/580,916 | 2017-11-02 | ||
| PCT/US2018/059080 WO2019090166A1 (en) | 2017-11-02 | 2018-11-02 | Diagnostic and prognostic methods for peripheral arterial diseases, aortic stenosis, and outcomes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021502573A JP2021502573A (ja) | 2021-01-28 |
| JP2021502573A5 true JP2021502573A5 (https=) | 2021-12-09 |
| JP7372251B2 JP7372251B2 (ja) | 2023-10-31 |
Family
ID=66332348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544567A Active JP7372251B2 (ja) | 2017-11-02 | 2018-11-02 | 末梢動脈疾患、大動脈弁狭窄症についての診断および予後の方法、ならびにアウトカム |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220229071A1 (https=) |
| EP (1) | EP3704491A4 (https=) |
| JP (1) | JP7372251B2 (https=) |
| CA (1) | CA3081752A1 (https=) |
| WO (1) | WO2019090166A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11657921B2 (en) | 2019-09-18 | 2023-05-23 | Tempus Labs, Inc. | Artificial intelligence based cardiac event predictor systems and methods |
| CN111803064A (zh) * | 2020-06-22 | 2020-10-23 | 燕山大学 | 基于eeg和血清炎症因子分析脑损伤标志物的方法 |
| WO2022060883A1 (en) * | 2020-09-16 | 2022-03-24 | Seattle Children's Hospital D/B/A Seattle Children's Research Institute | Diagnostic methods for kawasaki disease |
| US20230349926A1 (en) * | 2020-09-22 | 2023-11-02 | Ohio State Innovation Foundation | Methods, compositions, and kits for detecting and measuring endothelial injury in normal and diseased human central nervous system (cns) |
| WO2022251747A1 (en) * | 2021-05-28 | 2022-12-01 | Tempus Labs, Inc. | Ecg-based cardiovascular disease detection systems and related methods |
| WO2022254239A1 (en) * | 2021-06-01 | 2022-12-08 | University Of Hong Kong | Fibrosis biomarkers for non-alcoholic fatty liver disease |
| US20240266008A1 (en) * | 2023-02-01 | 2024-08-08 | Unlearn.AI, Inc. | Systems and Methods for Designing Augmented Randomized Trials |
| CN115938590B (zh) * | 2023-02-09 | 2023-05-02 | 四川大学华西医院 | 结直肠癌术后lars预测模型的构建方法及预测系统 |
| KR20250031367A (ko) * | 2023-08-28 | 2025-03-07 | 고려대학교 산학협력단 | 동맥경화증 진단용 엑소좀 유래 바이오 마커 |
| CN117031042B (zh) * | 2023-09-05 | 2024-05-31 | 上海爱谱蒂康生物科技有限公司 | 用于筛查诊断先天性心脏病胎儿的生物标志物及其应用 |
| CN117393171B (zh) * | 2023-12-11 | 2024-02-20 | 四川大学华西医院 | 直肠癌术后lars发展轨迹预测模型构建方法及系统 |
| CN120053650A (zh) * | 2025-01-23 | 2025-05-30 | 中南大学湘雅三医院 | Mmp10抑制剂在制备防治血管钙化的产品中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1756554A4 (en) * | 2004-06-03 | 2009-04-29 | Vermillion Inc | BIOMARKERS FOR PERIPHERAL ARTERY DISEASE |
| US20100331200A1 (en) * | 2006-03-31 | 2010-12-30 | Gordon Neal F | Post translational modification pattern analysis |
| WO2008057806A1 (en) * | 2006-11-01 | 2008-05-15 | Vermillion, Inc. | A panel of biomarkers for peripheral arterial disease |
| WO2009003142A1 (en) * | 2007-06-27 | 2008-12-31 | The Board Of Trustees Of The Leland, Stanford Junior University | Beta2-microglobulin and c reactive protein (crp) as biomarkers for peripheral artery disease |
| US20110065599A1 (en) * | 2009-08-07 | 2011-03-17 | Rules-Based Medicine, Inc. | Methods and Devices for Detecting Kidney Damage |
| AU2010328019A1 (en) * | 2009-12-09 | 2012-06-28 | Aviir, Inc. | Biomarker assay for diagnosis and classification of cardiovascular disease |
| CA2953789A1 (en) * | 2013-07-12 | 2015-01-15 | Emory University | Diagnostic assay to predict cardiovascular risk |
| JP6788879B2 (ja) * | 2015-06-24 | 2020-11-25 | 国立研究開発法人理化学研究所 | 末梢動脈疾患検査方法及び検査用試薬 |
| KR20180101595A (ko) * | 2016-02-01 | 2018-09-12 | 프리벤치오 인코포레이티드 | 심혈관 질환 및 사건을 위한 진단학적 및 예후적 방법 |
-
2018
- 2018-11-02 WO PCT/US2018/059080 patent/WO2019090166A1/en not_active Ceased
- 2018-11-02 JP JP2020544567A patent/JP7372251B2/ja active Active
- 2018-11-02 US US16/760,889 patent/US20220229071A1/en not_active Abandoned
- 2018-11-02 EP EP18872375.3A patent/EP3704491A4/en not_active Withdrawn
- 2018-11-02 CA CA3081752A patent/CA3081752A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021502573A5 (https=) | ||
| Massella et al. | Prevalence of hypertension in children with early-stage ADPKD | |
| Gonzalez-Juanatey et al. | Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease | |
| JP2019507354A5 (https=) | ||
| Foti et al. | Potential implications of the 2021 KDIGO blood pressure guideline for adults with chronic kidney disease in the United States | |
| Blackshear et al. | Remission of recurrent gastrointestinal bleeding after septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy‐associated acquired von Willebrand syndrome | |
| Samuel et al. | Diastolic dysfunction in women with ischemia and no obstructive coronary artery disease: Mechanistic insight from magnetic resonance imaging | |
| Carrie et al. | Augmented renal clearance in critically ill trauma patients: A pathophysiologic approach using renal vascular index | |
| Bradley et al. | Multidisciplinary aortopathy clinics should now be the standard of care in Canada | |
| RU2723626C1 (ru) | Способ прогнозирования течения сахарного диабета 2 типа с применением различных видов сахароснижающей терапии на основании оценки вариабельности гликемии | |
| Arican et al. | The role of right ventricular volumes and inferior vena cava diameters in the evaluation of volume status before colonoscopy | |
| Shibata et al. | Six-month trajectory of phase angle after cardiovascular surgery and associated factors of the recovery during cardiac rehabilitation: A retrospective cohort study | |
| Gombert et al. | Assessment of neurone-specific enolase, glial fibrillary acidic protein and S100 B as spinal cord ischemia biomarkers in patients undergoing open and endovascular complex aortic surgery: a single-center experience | |
| Lin et al. | Association of echocardiographic parameters with all-cause and cardiovascular mortality in patients with type 2 diabetes | |
| Wernhart et al. | Incidence of cardiovascular risk factors and exercise phenotyping in cardiomyopathies: one size does not fit all | |
| Ghafori et al. | The relationship between renal arterial resistive index (RRI) and renal outcomes in patients with resistant hypertension | |
| Katayama et al. | Coronary flow velocity pattern assessed noninvasively by transthoracic color Doppler echocardiography serves as a predictor of adverse cardiac events and left ventricular remodeling in patients with acute myocardial infarction | |
| RU2663078C1 (ru) | Способ прогнозирования риска развития послеоперационных сердечно-сосудистых осложнений лапароскопических операций при метастатическом раке толстой кишки | |
| RU2807270C1 (ru) | Способ прогнозирования улучшения почечной гемодинамики через 6 месяцев после процедуры симпатической денервации почечных артерий у больных резистентной артериальной гипертонией в сочетании с сахарным диабетом 2-го типа | |
| Murtazakhujayeva et al. | EARLY CLINICAL AND DIAGNOSTIC CRITERIA FOR RENAL DYSFUNCTION IN ARTERIAL HYPERTENSION | |
| Onyebeke et al. | Patterns of contraindications and initiation of guideline-directed medical therapy among older adults with heart failure, with and without polypharmacy | |
| Akhmadalieva | Diagnosis of the degree of liver fibrosis in patients with chronic hepatitis and cirrhosis of the liver | |
| Volkers et al. | P544 Point-of-care finger prick test for C-reactive protein, infliximab and adalimumab serum concentrations | |
| Bissessor et al. | The role of natriuretic peptides in patients with chronic complex (mixed or multiple) heart valve disease | |
| de Carvalho et al. | Early detection of acute kidney injury in critically ill children: Predictive value of renal arterial Doppler assessment |